Clara Yzet

1.4k total citations
79 papers, 492 citations indexed

About

Clara Yzet is a scholar working on Surgery, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clara Yzet has authored 79 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 34 papers in Genetics and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clara Yzet's work include Inflammatory Bowel Disease (34 papers), Gastric Cancer Management and Outcomes (26 papers) and Microscopic Colitis (18 papers). Clara Yzet is often cited by papers focused on Inflammatory Bowel Disease (34 papers), Gastric Cancer Management and Outcomes (26 papers) and Microscopic Colitis (18 papers). Clara Yzet collaborates with scholars based in France, United States and Italy. Clara Yzet's co-authors include Mathurin Fuméry, Franck Brazier, Momar Diouf, Éric Nguyen-Khac, Mathieu Pioche, Jérôme Rivory, Jean‐Frédéric Colombel, Ryan C. Ungaro, Anthony Buisson and Siddarth Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Clara Yzet

66 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Yzet France 12 331 263 203 105 92 79 492
Édouard Chabrun France 12 198 0.6× 204 0.8× 196 1.0× 52 0.5× 108 1.2× 25 453
Jean-François Simon France 5 509 1.5× 412 1.6× 268 1.3× 67 0.6× 75 0.8× 13 663
Gianluca Andrisani Italy 15 390 1.2× 346 1.3× 220 1.1× 130 1.2× 90 1.0× 48 721
Jorge Brito Portugal 9 255 0.8× 197 0.7× 280 1.4× 63 0.6× 67 0.7× 18 497
Lorena Rodríguez‐Alonso Spain 10 245 0.7× 237 0.9× 185 0.9× 50 0.5× 28 0.3× 27 421
Florin Costea Canada 6 182 0.5× 142 0.5× 248 1.2× 81 0.8× 58 0.6× 13 442
Renáta Bor Hungary 12 223 0.7× 187 0.7× 169 0.8× 63 0.6× 31 0.3× 74 468
Kristin Kaasen Jørgensen Norway 14 218 0.7× 271 1.0× 185 0.9× 135 1.3× 20 0.2× 35 577
Nina Levhar Israel 13 414 1.3× 211 0.8× 318 1.6× 30 0.3× 253 2.8× 23 596
Noritaka Takatsu Japan 13 233 0.7× 151 0.6× 252 1.2× 52 0.5× 115 1.3× 30 500

Countries citing papers authored by Clara Yzet

Since Specialization
Citations

This map shows the geographic impact of Clara Yzet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Yzet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Yzet more than expected).

Fields of papers citing papers by Clara Yzet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Yzet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Yzet. The network helps show where Clara Yzet may publish in the future.

Co-authorship network of co-authors of Clara Yzet

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Yzet. A scholar is included among the top collaborators of Clara Yzet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Yzet. Clara Yzet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delaire, J, et al.. (2025). P0400 Automated real-time detection of intestinal tract and inflammatory bowel disease in intestinal ultrasound with the vision transformer (ViT). Journal of Crohn s and Colitis. 19(Supplement_1). i896–i896. 1 indexed citations
2.
Fuméry, Mathurin, et al.. (2025). Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn’s disease. Therapeutic Advances in Gastroenterology. 18. 1128509447–1128509447.
5.
Yzet, Clara, et al.. (2024). P360 Prevalence and risk factors for fatigue in patients with inflammatory bowel disease and endoscopic healing. Journal of Crohn s and Colitis. 18(Supplement_1). i757–i757. 1 indexed citations
6.
Narula, Neeraj, Emily C L Wong, Parambir S. Dulai, et al.. (2024). P409 Optimal endoscopic healing thresholds defined by MM-SES-CD < 22.5 and SES-CD < 4 are associated with low risk of disease progression in Crohn’s disease. Journal of Crohn s and Colitis. 18(Supplement_1). i839–i840. 1 indexed citations
7.
Wils, Pauline, Nadia Arab, Aurélien Amiot, et al.. (2024). Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study. Digestive and Liver Disease. 56(8). 1312–1318. 2 indexed citations
8.
Yzet, Clara, Franck Brazier, Vincent Hautefeuille, et al.. (2024). Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional study. Clinics and Research in Hepatology and Gastroenterology. 48(7). 102387–102387. 5 indexed citations
10.
Buisson, Anthony, Maria Nachury, Clara Yzet, et al.. (2023). Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study. Alimentary Pharmacology & Therapeutics. 59(4). 526–534. 10 indexed citations
11.
12.
Yzet, Clara, Timothée Wallenhorst, Jérôme Rivory, et al.. (2023). Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video). Gastrointestinal Endoscopy. 98(4). 634–638. 3 indexed citations
15.
Buisson, Anthony, Maria Nachury, Maud Reymond, et al.. (2022). Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study. Clinical Gastroenterology and Hepatology. 21(9). 2338–2346.e3. 53 indexed citations
16.
Foulon, Arthur, et al.. (2020). Maladie chronique inflammatoire de l’intestin et grossesse : de la conception à la naissance. Gynécologie Obstétrique Fertilité & Sénologie . 48(6). 514–519. 4 indexed citations
17.
Kayal, Maia, Clara Yzet, Robert Hirten, et al.. (2019). Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis. Alimentary Pharmacology & Therapeutics. 50(11-12). 1189–1194. 17 indexed citations
18.
Yzet, Clara, Momar Diouf, Franck Brazier, et al.. (2019). Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 18(10). 2256–2261. 40 indexed citations
19.
Kayal, Maia, Clara Yzet, Parth Trivedi, et al.. (2019). Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients. Inflammatory Bowel Diseases. 26(7). 1079–1086. 51 indexed citations
20.
Yzet, Clara, et al.. (2019). Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?. Current Pharmaceutical Design. 25(1). 57–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026